2024 Kidney Cancer Clinical Updates and Research Highlights
Dana-Farber Cancer Institute via YouTube
Learn the Skills Netflix, Meta, and Capital One Actually Hire For
Build AI Apps with Azure, Copilot, and Generative AI — Microsoft Certified
Overview
AI, Data Science & Cloud Certificates from Google, IBM & Meta — 40% Off
One plan covers every Professional Certificate on Coursera. 40% off Coursera Plus Annual.
Unlock All Certificates
Watch a comprehensive 22-minute medical presentation from Dana-Farber Cancer Institute's Lank Center for Genitourinary Oncology covering essential kidney cancer clinical updates from ASCO GU 2024. Explore detailed discussions of key clinical trials including Keynote 564, Keynote 914, and Subcutaneous Novalab studies, along with important patient-reported outcomes and the latest research abstracts. Gain valuable insights into the most recent developments in kidney cancer treatment and research presented at this prestigious oncology conference.
Syllabus
Intro
Keynote 564
Keynote 914
Subcutaneous Novalab
PatientReported Outcomes
Clinical Trial Updates
Abstracts
Taught by
Dana-Farber Cancer Institute